These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

809 related items for PubMed ID: 1991807

  • 1. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
    Weissberger AJ, Ho KK, Lazarus L.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
    [Abstract] [Full Text] [Related]

  • 2. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
    Bellantoni MF, Harman SM, Cho DE, Blackman MR.
    J Clin Endocrinol Metab; 1991 Jan; 72(1):172-8. PubMed ID: 1824707
    [Abstract] [Full Text] [Related]

  • 3. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
    [Abstract] [Full Text] [Related]

  • 4. Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism.
    Ho KK, Weissberger AJ.
    J Bone Miner Res; 1992 Jul; 7(7):821-7. PubMed ID: 1642149
    [Abstract] [Full Text] [Related]

  • 5. The impact of dose and route of estrogen administration on the somatotropic axis in normal women.
    Lissett CA, Shalet SM.
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4668-72. PubMed ID: 14557438
    [Abstract] [Full Text] [Related]

  • 6. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women--a clinical research center study.
    Friend KE, Hartman ML, Pezzoli SS, Clasey JL, Thorner MO.
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2250-6. PubMed ID: 8964860
    [Abstract] [Full Text] [Related]

  • 7. Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex.
    Kam GY, Leung KC, Baxter RC, Ho KK.
    J Clin Endocrinol Metab; 2000 May; 85(5):1918-22. PubMed ID: 10843175
    [Abstract] [Full Text] [Related]

  • 8. A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency.
    Janssen YJ, Helmerhorst F, Frölich M, Roelfsema F.
    J Clin Endocrinol Metab; 2000 Jan; 85(1):464-7. PubMed ID: 10634425
    [Abstract] [Full Text] [Related]

  • 9. Regulation of growth hormone binding protein in man: comparison of gel chromatography and immunoprecipitation methods.
    Ho KK, Valiontis E, Waters MJ, Rajkovic IA.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):302-8. PubMed ID: 8432772
    [Abstract] [Full Text] [Related]

  • 10. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
    Slowinska-Srzednicka J, Zgliczynski S, Jeske W, Stopinska-Gluszak U, Srzednicki M, Brzezinska A, Zgliczynski W, Sadowski Z.
    J Endocrinol Invest; 1992 Feb; 15(7):533-8. PubMed ID: 1280287
    [Abstract] [Full Text] [Related]

  • 11. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG, Leung KC, Sullivan D, Reutens AT, Ho KK.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [Abstract] [Full Text] [Related]

  • 12. Effects of aging and estradiol supplementation on GH axis dynamics in women.
    Lieman HJ, Adel TE, Forst C, von Hagen S, Santoro N.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3918-23. PubMed ID: 11502833
    [Abstract] [Full Text] [Related]

  • 13. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.
    O'Sullivan AJ, Crampton LJ, Freund J, Ho KK.
    J Clin Invest; 1998 Sep 01; 102(5):1035-40. PubMed ID: 9727072
    [Abstract] [Full Text] [Related]

  • 14. Administration route-dependent effects of estrogens on IGF-I levels during fixed GH replacement in women with hypopituitarism.
    van der Klaauw AA, Biermasz NR, Zelissen PM, Pereira AM, Lentjes EG, Smit JW, van Thiel SW, Romijn JA, Roelfsema F.
    Eur J Endocrinol; 2007 Dec 01; 157(6):709-16. PubMed ID: 18057377
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
    O'Sullivan AJ, Ho KK.
    J Clin Endocrinol Metab; 1995 Jun 01; 80(6):1783-8. PubMed ID: 7775623
    [Abstract] [Full Text] [Related]

  • 16. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
    Wilson ME.
    J Clin Endocrinol Metab; 1998 Jun 01; 83(6):2018-28. PubMed ID: 9626134
    [Abstract] [Full Text] [Related]

  • 17. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P, Tsouderos Y, Marton I, Pelissier C, Varin C, Delmas PD.
    J Clin Endocrinol Metab; 1999 Jul 01; 84(7):2390-7. PubMed ID: 10404809
    [Abstract] [Full Text] [Related]

  • 18. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH, Naeraa RW, Fisker S, Christiansen JS.
    J Clin Endocrinol Metab; 1997 Aug 01; 82(8):2570-7. PubMed ID: 9253336
    [Abstract] [Full Text] [Related]

  • 19. Sex steroid regulation of growth hormone secretion and action.
    Ho KK, O'Sullivan AJ, Weissberger AJ, Kelly JJ.
    Horm Res; 1996 Aug 01; 45(1-2):67-73. PubMed ID: 8742122
    [Abstract] [Full Text] [Related]

  • 20. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 01; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.